Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.85 - $1.41 $20,710 - $34,354
-24,365 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $655 - $1,412
-565 Reduced 2.27%
24,365 $32,000
Q4 2021

Feb 14, 2022

SELL
$2.46 - $8.74 $1,077 - $3,828
-438 Reduced 1.73%
24,930 $61,000
Q3 2021

Nov 15, 2021

BUY
$5.1 - $9.39 $31,181 - $57,410
6,114 Added 31.75%
25,368 $217,000
Q2 2021

Aug 17, 2021

SELL
$3.95 - $6.88 $67,821 - $118,129
-17,170 Reduced 47.14%
19,254 $123,000
Q1 2021

May 17, 2021

BUY
$2.01 - $5.55 $5,788 - $15,984
2,880 Added 8.59%
36,424 $162,000
Q4 2020

Feb 16, 2021

BUY
$1.73 - $2.13 $58,031 - $71,448
33,544 New
33,544 $71,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.